Guidelines and management of hospitalized patients with community-acquired pneumonia: The Italian experience of the FASTCAP study;Linee guida e gestione ospedaliera delle polmoniti acquisite in comunità: L'esperienza italiana dello studio FASTCAP

Italian Journal of Medicine

Volumn 2, Issue 1, 2008, Pages 5-18

  Iori, Ido ^a,f   Gussoni, G ^a   Blasi, F ^b   Bulfoni, A ^c   Costantino, S ^d   Legnani, D ^e  

^a Centro Studi FADOI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Antibiotic therapy; Community acquired pneumonia; Outcome; Recommendations

Indexed keywords

BETA LACTAM; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCRIPTION;

EID: 45249089654     PISSN: 18779344     EISSN: None     Source Type: Journal    
DOI: 10.4081/itjm.2008.1.5     Document Type: Article

References (31)

1. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137 (9):977-88.
2. McFarlane JT, Colville A, Guion A, McFarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993;341(8844):511-4.
3. US Department of Health and Human Services, 1995.
4. Debbia EA, Mezzatesta ML, Stefani S, et al. Spettro di resistenza agli antibiotici in patogeni isolati in terapia intensiva: studio retrospettivo italiano. GIMMOC 2001;5:99-110.
5. Blasi F, Bulfoni A, Concia E, et al. Gestione delle infezioni delle basse vie respiratorie in Medicina Interna. GIMI 2002; 1(Suppl 2):1-69.
6. Woodhead M, Blasi F, Ewig S, et al; European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26 (6):1138-80.
7. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 (Suppl 2):S27-72.
8. Menéndez R, Torres A, Zalacain R, et al; NEUMOFAIL Group. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 2005;172(6):757-62.
9. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006; 130(3):794-9.
10. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336(4):243-50.
11. Lim WS, McFarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18(2):362-8.
12. Strausbaugh LJ, Sukumar SR, Joseph CL. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 2003;36(7):870-6.
13. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275(3):189-93.
14. Bellis P. Il progetto Minerva in Medicina Interna. Complessità e metodologia. Roma: Il Pensiero Scientifico, 2004.
15. Ali MH, Kalima P, Maxwell SR. Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres. J Antimicrob Chemother 2006;57 (5):959-62.
16. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275(2):134-41.
17. Fernández-Sabé N, Carratalà J, Rosón B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine 2003;82(3):159-69.
18. Ewig S, Torres A, Woodhead M. Assessment of pneumonia severity: a European perspective. Eur Respir J 2006;27(1): 6-8.
19. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31(2):383-421.
20. Esposito S. Outpatient parenteral treatment of bacterial infections: the Italian model as an international trend? J Antimicrob Chemother 2000;45(6):724-7.
21. Baddour LM, Yu VL, Klugman KP, et al; International Pneumococcal Study Group. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004;170(4):440-4.
22. Shefet D, Robenshtock E, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2005;(2):CD004418.
23. Blasi F, Iori I, Bulfoni A, et al. Can CAP-guidelines adherence improve patient outcome in internal medicine departments? (Submitted to Eur Respir J, Jan 2008.)
24. Bulfoni A, Concia E, Costantino S, et al (eds). Orientamenti terapeutici per il trattamento delle infezioni batteriche nel paziente anziano in Medicina Interna. Italian Journal Medicine 2007:1(2 Suppl).
25. Blasi F, Tarsia P. Value of short-course antimicrobial therapy in community-acquired pneumonia. Int J Antimicrob Agents 2005;26(Suppl 3):S148-55.
26. Kolditz M, Halank M, Höffken G. Short-course antimicrobial therapy for community-acquired pneumonia. Treat Respir Med 2005;4(4):231-9.
27. Oosterheert JJ, Bonten MJ, Schneider MM, et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006;333(7580):1193.
28. Lee RW, Lindstrom ST. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia. Respirology 2007;12(1):111-6.
29. Viale P, Scudeller L, Petrosillo N, et al. Clinical stability in human immunodeficiency virus-infected patients with community-acquired pneumonia. Clin Infect Dis 2004;38(2):271-9.
30. Ministero della Sanità. Direzione generale del sistema informativo e statistico e degli investimenti strutturali e tecnologici. Dati online.
31. Putinati S, Ballerin L, Piatella M, et al. La polmonite acquisita in comunità nell'anziano. Minerva Pneumol 2004;43: 99-106.